Skip to content

Author

N. Tsiamis

We have 5 of 34 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Comparative efficacy of clopidogrel and aspirin monotherapy after dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Optimal long-term antiplatelet monotherapy following percutaneous coronary intervention (PCI) remains debated, with aspirin traditionally recommended despite emerging evidence supporting P2Y12 inhibitor monotherapy. The comparison of clinical outcomes between clopidogrel and aspirin monotherapy in patients...

N. Ktenopoulos, K. Karampinos, A. Apostolos et al. · 0 citations
Review Open access Oct 2026

Assessing Calcified Coronary Lesions to Guide Percutaneous Coronary Intervention: From Angiography to Intracoronary Imaging

Simple Summary Calcium in the coronary arteries makes them stiff and difficult to treat, and the amount, depth, and pattern of calcium strongly influence whether an intracoronary device can be delivered successfully. The severity of coronary calcium is a strong predictor of worse outcomes during percutaneous coronary i...

Sotirios C. Kotoulas, A. Triantafyllis, Athanasios C. Kotoulas et al. · 0 citations
Open access Oct 2026

Safety and effectiveness of drug-coated balloon angioplasty in de novo coronary lesions: 6-month outcomes from a multicenter registry

Drug-coated balloon (DCB) angioplasty has emerged as a promising alternative to drug eluting stent (DES) implantation, particularly in small-vessel coronary disease (defined as target vessels with a reference diameter ≤2.75 mm). Nevertheless, multicenter real-world data focusing exclusively on de novo lesions remain...

N. Tsiamis, A. Papanikolaou, F. Toulgaridis et al. · 0 citations
Open access Oct 2026

Comparative effectiveness of lipid-lowering regimens for achieving ESC LDL-cholesterol targets in acute coronary syndrome: a real-world cohort analysis

Baseline LDL-C category analysis revealed that patients with baseline LDL-C ≥160 mg/dL required triple therapy to reach guideline targets, while those with baseline LDL-C <100 mg/dL achieved targets with high-intensity statin monotherapy.

N. Tsiamis, A. Romiou, D. Zacharakis et al. · 0 citations
Review Open access Jul 2026

Multimodality echocardiography in structural heart disease: the evolving role of the interventional imager

This review outlines the expanding role of echocardiography across the spectrum of TSHIs, highlighting the importance of multimodality imaging, including three-dimensional transoesophageal echocardiography (3D TEE), intracardiac echocardiography (ICE) and fusion imaging techniques, for comprehensive structural evaluati...

N. Ktenopoulos, K. Vlasopoulou, P. Vlachakis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.